(74) reported a multi-focal GBM patient treated with resection followed by intravenous IL-13Rα2 CAR-T infusion, leading to lesion shrinkage and disease stabilization for 7.5 months, indicating preliminary efficacy in HGG treatment. The gene discussed is IL13RA2; the disease is glioblastoma.